Hanmi Pharmaceutical 1 trillion8,000 billion technology-transfer and export deals prompt brokers to raise target prices

Hanmi Pharmaceutical 6 month 2 day, it announced that it had signed an export contract with Eli Lilly. Securities firms subsequently raised their target prices for Hanmi Pharmaceutical. Earlier, Hanmi Pharmaceutical disclosed a technology-transfer agreement worth 1 trillion 8,000 billion won, prompting its shares to strengthen.

Hyundai Motor said its collaboration with Boston Dynamics had entered a concrete stage. Some securities firms set Hyundai Motor’s target price at 100 ten thousand won. News related to the collaboration drew attention to the movement of related shares.

Hyundai Mobis presented a positive outlook for its actuator business. Securities firms raised their target prices for Hyundai Mobis. The company explained its plan to strengthen its electrification-parts business.

NH Investment & Securities 4,000disclosed that it had decided on a rights offering worth ... won. The company said it would use the funds to strengthen its competitiveness in IMA (electrification components). The decision to proceed with the rights offering was accompanied by disclosure of changes to NH Investment & Securities’ capital structure.

In the market, disclosures of contracts and investments by the companies mentioned above, along with revisions to securities firms’ target prices, led to changes in trading volumes and share prices of individual stocks. Each company explained the details of its contracts and the intended use of funds in its disclosures. Further details are expected to be set out through additional disclosures or schedule announcements.